Background: Bone regeneration after critical-size defects remains a major clinical challenge, and current grafting approaches are limited by their morbidity, immunogenicity, and availability. Pharmaco
Background: Bone regeneration after critical-size defects remains a major clinical challenge, and current grafting approaches are limited by their morbidity, immunogenicity, and availability. Pharmaco
